Ipsen to Acquire Clementia Pharmaceuticals to Significantly Boost Rare Disease Portfolio

By | February 25th, 2019|News|

Ipsen to Acquire Clementia Pharmaceuticals to Significantly Boost Rare Disease [...]

The Science of Commercialization

By | January 30th, 2019|Bloom Burton, News|

November 8, 2018; Hamilton, Ontario, Canada; Triumvira is a [...]

Greenbrook TMS Announces Closing of Private Placement Totaling USD $20,000,000

By | June 7th, 2018|Bloom Burton, Financing, News|

Toronto, ON — June 7, 2018 — Greenbrook TMS, the largest provider [...]

CannTrust™ Announces Closing of $100,395,000 Bought Deal

By | June 5th, 2018|Bloom Burton, Financing, News|

VAUGHAN, ON, June 5, 2018 /CNW/ – CannTrust Holdings Inc. (TSX: TRST) (“CannTrust” [...]

Bloom Burton & Co. Welcomes Michael J. Brown, CFA® as Portfolio Manager and Chief Executive Officer of its Asset Management Affiliate, Bloom Burton Investment Group.

By | May 30th, 2018|Bloom Burton, News|

TORONTO, May 30, 2018 – Bloom Burton & Co. (“Bloom [...]

Kneat Announces Closing of $6.185 Million Brokered Private Placement

By | April 24th, 2018|Financing, News|

HALIFAX, April 10, 2018 –, inc. (TSX-V: KSI) (“Kneat” [...]

Sunniva Inc. Closes $27.8 Million Bought Deal Public Offering

By | March 27th, 2018|Financing, News|

VANCOUVER, BC – March 27, 2018 – Sunniva Inc. (“Sunniva” [...]

Immunovaccine Announces Closing of CAD$14,375,000 Bought Deal Offering with Over-Allotment Option Exercised in Full

By | March 6th, 2018|Bloom Burton, Financing, News|

HALIFAX, N.S., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. [...]

Bloom Burton & Co. Announces the 2018 Bloom Burton Award Gala

By | February 12th, 2018|Bloom Burton, News|

Annual Award Recognizes the Most Significant Contributor to Canada’s Innovative [...]

ESSA Completes US$26 Million Equity Offering

By | January 19th, 2018|Financing, News|

  Read the full press release here.